The Recent Advancements in the Early Detection of Cancer Biomarkers by Dnazyme-Assisted Aptasensors

The Recent Advancements in the Early Detection of Cancer Biomarkers by Dnazyme-Assisted Aptasensors Publisher Pubmed

Kamali H^{1, 3} ; Golmohammadzadeh S^{2, 3} ; Zare H⁴ ; Nosrati R⁵ ; Fereidouni M⁶ ; Safarpour H⁶

Show Affiliations

1. Targeted Drug Delivery Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran
2. Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran
3. Department of Pharmaceutics, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
4. Recombinant Proteins Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran
5. Cellular and Molecular Research Center, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran
6. Cellular and Molecular Research Center, Birjand University of Medical Sciences, Birjand, Iran

Source: Journal of Nanobiotechnology Published:2022

Abstract

Abstract: Clinical diagnostics rely heavily on the detection and quantification of cancer biomarkers. The rapid detection of cancer-specific biomarkers is of great importance in the early diagnosis of cancers and plays a crucial role in the subsequent treatments. There are several different detection techniques available today for detecting cancer biomarkers. Because of target-related conformational alterations, high stability, and target variety, aptamers have received considerable interest as a biosensing system component. To date, several sensitivity-enhancement strategies have been used with a broad spectrum of nanomaterials and nanoparticles (NPs) to improve the limit and sensitivity of analyte detection in the construction of innovative aptasensors. The present article aims to outline the research developments on the potential of DNAzymes-based aptasensors for cancer biomarker detection. Graphical Abstract: [Figure not available: see fulltext.]. © 2022, The Author(s).

Related Docs

View other Related Docs

1. The Recent Progress in the Early Diagnosis of Acute Myocardial Infarction Based on Myoglobin Biomarker: Nano-Aptasensors Approaches, Journal of Pharmaceutical and Biomedical Analysis (2022)

2. New Insight Into G-Quadruplexes; Diagnosis Application in Cancer, Analytical Biochemistry (2021)

3. Recent Progress in the Graphene-Based Biosensing Approaches for the Detection of Alzheimer's Biomarkers, Journal of Pharmaceutical and Biomedical Analysis (2023)

4. Noble Metal Nanoparticles in Biosensors: Recent Studies and Applications, Nanotechnology Reviews (2017)

5. Biosensing Using Dna-Based Structures Integrated With Nanosheets, Microchemical Journal (2023)

6. Increasing the Sensitivity and Accuracy of Detecting Exosomes As Biomarkers for Cancer Monitoring Using Optical Nanobiosensors, Cancer Cell International (2024)

7. Electrochemical Mirna Biosensors: The Benefits of Nanotechnology, Nanomedicine Research Journal (2017)

8. Recent Advances in the Fabrication of Nano-Aptasensors for the Detection of Troponin As a Main Biomarker of Acute Myocardial Infarction, Critical Reviews in Analytical Chemistry (2023)

Experts (# of related papers)

View all Related Experts

Mahmood Naderi (1)

Vahid Haghpanah (1)

Style	Citing Format
MLA	Kamali H, et al.. "The Recent Advancements in the Early Detection of Cancer Biomarkers by Dnazyme-Assisted Aptasensors." Journal of Nanobiotechnology, vol. 20, no. 1, 2022, pp. -.
APA	Kamali H, Golmohammadzadeh S, Zare H, Nosrati R, Fereidouni M, Safarpour H (2022). The Recent Advancements in the Early Detection of Cancer Biomarkers by Dnazyme-Assisted Aptasensors. Journal of Nanobiotechnology, 20(1), -.
Chicago	Kamali H, Golmohammadzadeh S, Zare H, Nosrati R, Fereidouni M, Safarpour H. "The Recent Advancements in the Early Detection of Cancer Biomarkers by Dnazyme-Assisted Aptasensors." Journal of Nanobiotechnology 20, no. 1 (2022): -.
Harvard	Kamali H et al. (2022) 'The Recent Advancements in the Early Detection of Cancer Biomarkers by Dnazyme-Assisted Aptasensors', Journal of Nanobiotechnology, 20(1), pp. -.
Vancouver	Kamali H, Golmohammadzadeh S, Zare H, Nosrati R, Fereidouni M, Safarpour H. The Recent Advancements in the Early Detection of Cancer Biomarkers by Dnazyme-Assisted Aptasensors. Journal of Nanobiotechnology. 2022;20(1):-.
BibTex	@article{ author = {Kamali H and Golmohammadzadeh S and Zare H and Nosrati R and Fereidouni M and Safarpour H}, title = {The Recent Advancements in the Early Detection of Cancer Biomarkers by Dnazyme-Assisted Aptasensors}, journal = {Journal of Nanobiotechnology}, volume = {20}, number = {1}, pages = {-}, year = {2022} }
RIS	TY - JOUR AU - Kamali H AU - Golmohammadzadeh S AU - Zare H AU - Nosrati R AU - Fereidouni M AU - Safarpour H TI - The Recent Advancements in the Early Detection of Cancer Biomarkers by Dnazyme-Assisted Aptasensors JO - Journal of Nanobiotechnology VL - 20 IS - 1 SP - EP - PY - 2022 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract